A novel microRNA signature associated with cisplatin resistant NSCLC holds both diagnostic and prognostic biomarker potential

被引：0
|
作者：
MacDonagh, L. [1 ,2 ]
Gray, S. G. [1 ,2 ]
Cuffe, S. [1 ,2 ]
Finn, S. P. [1 ,2 ,3 ]
Young, V. [4 ]
Ryan, R. [4 ]
Nicholson, S. [3 ]
Leonard, N. [3 ]
Sui, J. Sze Yin [1 ,2 ]
O'Byrne, K. J. [5 ]
Barr, M. P. [1 ,2 ]
机构：
[1] St James Hosp, Thorac Oncol Res Grp, Inst Mol Med, Trinity Ctr Hlth Sci, Dublin 8, Ireland
[2] Univ Dublin Trinity Coll, Dublin 2, Ireland
[3] St James Hosp, Dept Histopathol, Dublin 8, Ireland
[4] St James Hosp, Dept Cardiothorac Surg, Dublin 8, Ireland
[5] Queensland Univ Technol, Canc & Ageing Res Program, Brisbane, Qld 4001, Australia
来源：
LUNG CANCER | 2016年 / 91卷
关键词：
D O I：
10.1016/S0169-5002(16)30022-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5
引用
收藏
页码：S2 / S3
页数：2
相关论文
共 50 条
  • [31] MicroRNA as a potential diagnostic and prognostic biomarker in brain gliomas: a systematic review and meta-analysis
    Hasani, Fatemeh
    Masrour, Mahdi
    Jazi, Kimia
    Ahmadi, Payam
    Hosseini, Saba sadat
    Lu, Victor M.
    Alborzi, Amirmohammad
    FRONTIERS IN NEUROLOGY, 2024, 15
  • [32] Identification of a three miRNA signature as a novel potential prognostic biomarker in patients with bladder cancer
    Peng, Fei
    Li, Hui
    Xiao, Hailang
    Li, Ling
    Li, Yan
    Wu, Yi
    ONCOTARGET, 2017, 8 (62) : 105553 - 105560
  • [33] Evaluation of the diagnostic and prognostic potential of the novel inflammatory biomarker suPAR in pleural effusion
    Matzkies, L.
    Flick, H.
    Rabensteiner, J.
    Feierl, G.
    Hoenigl, M.
    Raggam, R.
    Prattes, J.
    WIENER KLINISCHE WOCHENSCHRIFT, 2016, 128 : S387 - S387
  • [34] HYAL4 is a novel potential prognostic and diagnostic biomarker for bladder cancer
    Escudero, Diogo
    CANCER RESEARCH, 2012, 72
  • [35] Systematic analyses of a novel lncRNA-associated signature as the prognostic biomarker for Hepatocellular Carcinoma
    Sui, Jing
    Miao, Yan
    Han, Jiali
    Nan, Hongmei
    Shen, Bo
    Zhang, Xiaomei
    Zhang, Yan
    Wu, Yuan
    Wu, Wenjuan
    Liu, Tong
    Xu, Siyi
    Yang, Sheng
    Yin, Lihong
    Pu, Yuepu
    Liang, Geyu
    CANCER MEDICINE, 2018, 7 (07): : 3240 - 3256
  • [36] RanBP9 is a Novel Prognostic and Predictive Biomarker for NSCLC and Affects Cellular Response to Cisplatin and PARP Inhibitors
    Tessari, A.
    Palmieri, D.
    Pawlikowski, M.
    Parbhoo, K.
    Foray, C.
    Fassan, M.
    La Perle, K.
    Rulli, E.
    Fabbri, A.
    Ganzinelli, M.
    Embrione, V.
    Broggini, M.
    Amann, J.
    Carbone, D.
    Garassino, M.
    Croce, C.
    Coppola, V.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2122 - S2123
  • [37] Identification of miRNA-Based Signature as a Novel Potential Prognostic Biomarker in Patients with Breast Cancer
    Tang, Jia
    Ma, Wei
    Zeng, Qinlong
    Tan, Jieliang
    Cao, Keshen
    Luo, Liangping
    DISEASE MARKERS, 2019, 2019
  • [38] Identification of A Six-MRNA Signature as a Novel Potential Prognostic Biomarker in Pediatric Wilms Tumor
    Kang, W.
    Song, F.
    Hu, J.
    Zhao, Q.
    PEDIATRIC BLOOD & CANCER, 2021, 68 : S243 - S243
  • [39] Identification of a five-mRNA signature as a novel potential prognostic biomarker in pediatric Wilms tumor
    Lin, Xiao-Dan
    Wu, Yu-Peng
    Chen, Shao-Hao
    Sun, Xiong-Lin
    Ke, Zhi-Bin
    Chen, Dong-Ning
    Li, Xiao-Dong
    Lin, Yun-Zhi
    Wei, Yong
    Zheng, Qing-Shui
    Xu, Ning
    Xue, Xue-Yi
    MOLECULAR GENETICS & GENOMIC MEDICINE, 2020, 8 (01):
  • [40] Identification of a five-miRNA signature as a novel potential prognostic biomarker in patients with nasopharyngeal carcinoma
    Tu, Bo
    Ye, Ling
    Cao, Qingsong
    Gong, Sisi
    Jiang, Miaohua
    Li, Hui
    HEREDITAS, 2022, 159 (01)
12345